Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
188,679,245
Total 13F shares
14,822,157
Share change
+704,729
Total reported value
$388,292,611
Price per share
$26.15
Number of holders
51
Value change
+$18,199,344
Number of buys
29
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
3.8%
7,088,651
$230,168,000 30 Sep 2016
13F
FMR LLC
13F
Company
0.99%
1,861,849
$60,454,000 30 Sep 2016
13F
New Leaf Venture Partners, L.L.C.
13F
Company
0.42%
784,159
$25,462,000 30 Sep 2016
13F
Foresite Capital Management III, LLC
13F
Company
0.39%
727,496
$23,622,000 30 Sep 2016
13F
Redmile Group, LLC
13F
Company
0.37%
701,822
$22,788,000 30 Sep 2016
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.36%
683,448
$22,191,000 30 Sep 2016
13F
Cormorant Asset Management, LP
13F
Company
0.27%
507,907
$16,492,000 30 Sep 2016
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.2%
380,000
$12,339,000 30 Sep 2016
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.13%
246,903
$8,017,000 30 Sep 2016
13F
BlackRock Fund Advisors
13F
Company
0.11%
203,599
$6,611,000 30 Sep 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.08%
142,320
$4,621,000 30 Sep 2016
13F
VANGUARD GROUP INC
13F
Company
0.06%
122,198
$3,967,000 30 Sep 2016
13F
STATE STREET CORP
13F
Company
0.05%
102,838
$3,339,000 30 Sep 2016
13F
NORTHERN TRUST CORP
13F
Company
0.05%
91,433
$2,969,000 30 Sep 2016
13F
JENNISON ASSOCIATES LLC
13F
Company
0.04%
75,435
$2,449,000 30 Sep 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
67,231
$2,182,000 30 Sep 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.03%
57,306
$1,861,000 30 Sep 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.01%
28,000
$909,000 30 Sep 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.01%
27,959
$908,000 30 Sep 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.01%
21,608
$702,000 30 Sep 2016
13F
Bank of New York Mellon Corp
13F
Company
0.01%
21,343
$693,000 30 Sep 2016
13F
Vident Investment Advisory, LLC
13F
Company
0.01%
19,342
$628,000 30 Sep 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
15,709
$510,000 30 Sep 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.01%
11,898
$386,000 30 Sep 2016
13F
Matisse Capital
13F
Company
0.01%
10,296
$334,000 30 Sep 2016
13F
RHUMBLINE ADVISERS
13F
Company
0%
7,862
$255,000 30 Sep 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0%
7,700
$250,000 30 Sep 2016
13F
Lesa Sroufe & Co
13F
Company
0%
6,440
$209,000 30 Sep 2016
13F
STRS OHIO
13F
Company
0%
6,000
$194,000 30 Sep 2016
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
5,420
$176,000 30 Sep 2016
13F
Nationwide Fund Advisors
13F
Company
0%
4,661
$151,000 30 Sep 2016
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0%
4,264
$138,452 30 Sep 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0%
4,264
$138,000 30 Sep 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
4,200
$136,000 30 Sep 2016
13F
UBS Group AG
13F
Company
0%
3,000
$97,000 30 Sep 2016
13F
MORGAN STANLEY
13F
Company
0%
2,309
$75,000 30 Sep 2016
13F
DEUTSCHE BANK AG\
13F
Company
0%
1,216
$39,000 30 Sep 2016
13F
CITIGROUP INC
13F
Company
0%
605
$20,000 30 Sep 2016
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
552
$17,923 30 Sep 2016
13F
PRENTISS SMITH & CO INC
13F
Company
0%
500
$16,000 30 Sep 2016
13F
BlackRock Finance, Inc.
13F
Company
0%
373
$12,000 30 Sep 2016
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
307
$10,000 30 Sep 2016
13F
ROYAL BANK OF CANADA
13F
Company
0%
300
$10,000 30 Sep 2016
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
220
$7,000 30 Sep 2016
13F
Acrospire Investment Management LLC
13F
Company
0%
164
$5,000 30 Sep 2016
13F
BARCLAYS PLC
13F
Company
0%
46
$1,000 30 Sep 2016
13F

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q4 2016

As of 31 Dec 2016, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,822,157 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, FMR LLC, Redmile Group, LLC, Foresite Capital Management III, LLC, PERCEPTIVE ADVISORS LLC, New Leaf Venture Partners, L.L.C., Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, EVENTIDE ASSET MANAGEMENT, LLC, and BlackRock Fund Advisors. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders
45
Q4 2016 holders
51
Holder diff
6
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 Value $ Q4 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .